Discussion. Tamoxifen increases the risk of microvascular flap complications in patients undergoing microvascular breast reconstruction. Article uri icon

Overview

publication date

  • February 1, 2012

Research

keywords

  • Antineoplastic Agents, Hormonal
  • Mammaplasty
  • Surgical Flaps
  • Tamoxifen

Identity

Scopus Document Identifier

  • 84856748919

Digital Object Identifier (DOI)

  • 10.1097/PRS.0b013e31823aeccd

PubMed ID

  • 22286414

Additional Document Info

volume

  • 129

issue

  • 2